QA: Oncotelic Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000908259_2023_Oncotelic_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0000908259, Oncotelic Therapeutics Inc.

  xvar xval
0 AssetsCurrent 303,164
1 IntangibleAssetsNetIncludingGoodwill 12,071,376
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 23,742,279
4 LiabilitiesCurrent 16,923,407
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,853,664
9 ResearchAndDevelopmentExpense 756,910
10 remainder_Expenses 4,111,079
11 remainder_Revenues 0
12 remainder_NetIncome 14,398,256
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 36,116,819
1 Liabilities 16,923,407
2 Expenses 9,721,653
3 Revenues 0
4 StockholdersEquity 19,193,412
5 NetIncome 4,676,603
6 ComprehensiveNetIncome 4,676,603
7 BaseVar 38,580,068
8 EconomicCapitalRatio 1.42

Edgar->Model Mapping

Feature Distribution

Change over Time